Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting
Svenningsson, Anders, Falk, Eva, Celius, Elisabeth G, Fuchs, Siegrid, Schreiber, Karen, Berkö, Sara, Sun, Jennifer, Penner, Iris-Katharina
Published in PloS one (21.03.2013)
Published in PloS one (21.03.2013)
Get full text
Journal Article
Survival in patients diagnosed with SMA at less than 24 months of age in a population-based setting before, during and after introduction of nusinersen therapy. Experience from Sweden
Berglund, Anders, Berkö, Sara, Lampa, Erik, Sejersen, Thomas
Published in European journal of paediatric neurology (01.09.2022)
Published in European journal of paediatric neurology (01.09.2022)
Get full text
Journal Article
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness
Penner, Iris-Katharina, Sivertsdotter, Eva Catharina, Celius, Elisabeth G, Fuchs, Siegrid, Schreiber, Karen, Berkö, Sara, Svenningsson, Anders
Published in Frontiers in neurology (2015)
Published in Frontiers in neurology (2015)
Get full text
Journal Article
Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting. e58643
Svenningsson, Anders, Falk, Eva, Celius, Elisabeth G, Fuchs, Siegrid, Schreiber, Karen, Berko, Sara, Sun, Jennifer, Penner, Iris-Katharina
Published in PloS one (01.03.2013)
Published in PloS one (01.03.2013)
Get full text
Journal Article